Medical News

RSS

SAGE announces the launch of "Therapeutic Advances in Musculoskeletal Disease"

SAGE has announced the launch of Therapeutic Advances in Musculoskeletal Disease, the latest in SAGE's highly-regarded Therapeutic Advances series.

22 Oct 2009

SAEC to collaborate with HMORN to improve the safe use of drugs

The International Serious Adverse Events Consortium (SAEC) announced today it will collaborate with the HMO Research Network (HMORN) to improve the safe use of drugs by exploring why the genetic makeup of some individuals makes them more likely to experience serious drug-related adverse events (SAEs).

22 Oct 2009

Researchers develop a new test process for cancer drugs

It is very difficult to predict whether a cancer drug will help an individual patient: only around one third of drugs will work directly in a given patient. Researchers at the Heinz Nixdorf Chair for Medical Electronics at the Technische Universitaet Muenchen (TUM) have developed a new test process for cancer drugs.

22 Oct 2009

Clinical performance study reveals the accuracy and precision of TRUE2go system

Home Diagnostics, Inc., a leading developer, manufacturer, and marketer of blood glucose monitoring systems, today announced the results of a TRUE2go™ clinical performance study published in the October 2009 issue of the journal Diabetes Technology & Therapeutics. The study, “Clinical Performance of the TRUE2go Blood Glucose System – A Novel Integrated System for Meter and Strips,” demonstrated the accuracy and precision of the TRUE2go system and found that it was both easy and convenient to use by patients.

22 Oct 2009

Industries oppose proposed assisted living regulations

With Pennsylvania just weeks away from the publication of final assisted living regulations, recently-released survey results about the size of living units in existing facilities show the wisdom of the proposed rules -- and the absurdity of the industry's opposition.

22 Oct 2009

Sosei Group announces Phase III trials update on NVA237 and QVA149

Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), announces that the Phase III trials with NVA237, which commenced in June 2009, are proceeding to plan. Initiation of Phase III studies with QVA149 is now expected to occur during 2010.

22 Oct 2009

Web-savvy johns use the Internet to warn of prostitution hot zones and stings, Study finds

The Internet has spawned a virtual subculture of "johns" who share information electronically about prostitution, potentially making them harder to catch, according to a new study co-authored by a Michigan State University criminologist.

22 Oct 2009

Plant-based foods could help fight obesity and heart disease

The cheeseburger and French fries might look tempting, but eating a serving of broccoli or leafy greens first could help people battle metabolic processes that lead to obesity and heart disease, a new University of Florida study shows.

22 Oct 2009

SNAP Diagnostics joins SAFE-BioPharma Association

SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. SNAP Diagnostics is the first dedicated device and diagnostics company to join SAFE-BioPharma.

22 Oct 2009

Awareness campaign to educate families on H1N1 flu virus, seasonal flu and common cold

Dial Complete Antibacterial Foaming Hand Wash, the #1 doctor-recommended brand, today announced it is working together with other leading brands to raise awareness and educate families to ‘Plan, Prepare and Defend’ against the H1N1 flu virus, seasonal flu and the common cold.

22 Oct 2009

Ohio ranks fourth in bioscience industry

While other states jockeyed for position on Business Facilities Magazine's second-annual Biotechnology Strength Report, Ohio defended its ranking as best in the Midwest and No. 4 in the nation for its strengths in the bioscience industry.

22 Oct 2009

People in developing countries spend 90% of all medical expenditures for diabetes care

Type 2 diabetes is often seen as a condition affecting older, unproductive adults in wealthy countries. However, the reality is that 70% of people with diabetes now live in low and middle-income countries and the economic impact of diabetes is much greater in poorer countries.

22 Oct 2009

Toolkit to help U.S. employers address the growing problem of childhood obesity

Saying that employers can no longer afford to ignore the epidemic of childhood obesity, the National Business Group on Health today announced the launch of "Childhood Obesity: It's Everyone's Business," a toolkit designed to help U.S. employers address the growing problem of overweight and obese children.

22 Oct 2009

HBO treatments may improve neurological outcome after traumatic brain injury

Hard to Treat Diseases, Inc. (HTDS:PK), http://www.htdsmedical.com announced that researchers in its Slavica BioChem division have reported new positive results of experiments in which the potential beneficial effects of Hyperbaric oxygenation (HBO) after traumatic brain injury have been explored.

22 Oct 2009

ISTA Pharmaceuticals' presentations on Phase 3 clinical results of Bepreve

ISTA Pharmaceuticals, Inc. today announced poster presentations of results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies in allergic conjunctivitis. The studies demonstrated Bepreve was safe and well-tolerated when given twice daily for six weeks in a healthy pediatric population as young as three years of age.

22 Oct 2009

Women are better than men at distinguishing between emotions: Study

Women are better than men at distinguishing between emotions, especially fear and disgust, according to a new study published in the online version of the journal Neuropsychologia. As part of the investigation, Olivier Collignon and a team from the Universit- de Montr-al Centre de recherche en neuropsychologie et cognition (CERNEC) demonstrated that women are better than men at processing auditory, visual and audiovisual emotions.

22 Oct 2009

Researchers develop a non-invasive test to help assess embryo viability for IVF

Embryos that are most likely to result in a pregnancy are crucial to the success of in vitro fertilization (IVF) but are difficult to identify. Researchers at Yale School of Medicine, led by Emre Seli, M.D., are developing a fast, non-invasive test to help assess embryo viability for IVF.

22 Oct 2009

AHA endorses rL Solutions' Risk MonitorPro healthcare incident management system

The American Hospital Association (AHA) today announced it has exclusively endorsed rL Solutions Risk MonitorPro® for healthcare incident management. Risk MonitorPro is a web-based incident and adverse event management system that allows users to easily submit, refine, analyze and communicate critical incident information.

22 Oct 2009

GeckoSystems to discuss its sensor fusion based vision system

GeckoSystems Intl. Corp. (http://www.geckosystems.com/) -- announced today that during their first annual "Mobile Robots in Motion" conference November 4-5, 2009 attendees will be able to observe and discuss GeckoSystems' sensor fusion based vision system, the CompoundSensorArray™.

22 Oct 2009

Cephalon announces receipt of a Paragraph IV Certification Notice Letter regarding ANDA

Cephalon, Inc. (Nasdaq: CEPH) today announced receipt of a Paragraph IV Certification Notice Letter on October 20, 2009 regarding an Abbreviated New Drug Application (ANDA) submitted to the U.S. Food and Drug Administration (FDA) by Teva Pharmaceuticals USA, Inc. requesting approval to market and sell a generic version of the 50 mg, 100 mg, 150 mg, 200 mg and 250 mg strengths of NUVIGIL® (armodafinil) Tablets [C-IV].

22 Oct 2009